Kaiser Permanente prior authorization criteria
Documentation packets and P2P preparation by drug—for prescribers and PA staff. Verify the current member-specific payer criteria and timing before submission.
Kaiser Permanente reviews prior-authorization requests against its published medical policies — diagnosis with ICD-10 code, documented step-therapy history, and prescriber attestation of medical necessity. The applicable product, plan terms, request type, urgency, and governing law determine the decision and appeal clocks. Confirm both in the current member-specific source and denial notice. Criteria by drug appear below.
Prior authorization criteria by drug
Each page covers Kaiser Permanente's submission criteria, the documentation packet, and peer-to-peer prep for that drug.
- Adalimumab at Kaiser Permanente →
- Aflibercept at Kaiser Permanente →
- Apixaban at Kaiser Permanente →
- Atezolizumab at Kaiser Permanente →
- Atogepant at Kaiser Permanente →
- Benralizumab at Kaiser Permanente →
- Bevacizumab at Kaiser Permanente →
- Bictegravir at Kaiser Permanente →
- Buprenorphine at Kaiser Permanente →
- Dapagliflozin at Kaiser Permanente →
- Dulaglutide at Kaiser Permanente →
- Dupilumab at Kaiser Permanente →
- Eculizumab at Kaiser Permanente →
- Elexacaftor Tezacaftor Ivacaftor at Kaiser Permanente →
- Empagliflozin at Kaiser Permanente →
- Erenumab at Kaiser Permanente →
- Evolocumab at Kaiser Permanente →
- Faricimab at Kaiser Permanente →
- Fingolimod at Kaiser Permanente →
- Fremanezumab at Kaiser Permanente →
- Galcanezumab at Kaiser Permanente →
- Glecaprevir Pibrentasvir at Kaiser Permanente →
- Guselkumab at Kaiser Permanente →
- Ibrutinib at Kaiser Permanente →
- Imatinib at Kaiser Permanente →
- Inclisiran at Kaiser Permanente →
- Infliximab at Kaiser Permanente →
- Ixekizumab at Kaiser Permanente →
- Lenalidomide at Kaiser Permanente →
- Liraglutide at Kaiser Permanente →
- Lisdexamfetamine at Kaiser Permanente →
- Mepolizumab at Kaiser Permanente →
- Methylphenidate at Kaiser Permanente →
- Naltrexone at Kaiser Permanente →
- Natalizumab at Kaiser Permanente →
- Nintedanib at Kaiser Permanente →
- Nivolumab at Kaiser Permanente →
- Nusinersen at Kaiser Permanente →
- Ocrelizumab at Kaiser Permanente →
- Ofatumumab at Kaiser Permanente →
- Omalizumab at Kaiser Permanente →
- Ozanimod at Kaiser Permanente →
- Palbociclib at Kaiser Permanente →
- Pembrolizumab at Kaiser Permanente →
- Pirfenidone at Kaiser Permanente →
- Ribociclib at Kaiser Permanente →
- Rimegepant at Kaiser Permanente →
- Risankizumab at Kaiser Permanente →
- Rituximab at Kaiser Permanente →
- Rivaroxaban at Kaiser Permanente →
- Sacubitril Valsartan at Kaiser Permanente →
- Secukinumab at Kaiser Permanente →
- Semaglutide at Kaiser Permanente →
- Sofosbuvir at Kaiser Permanente →
- Tafamidis at Kaiser Permanente →
- Tenofovir Alafenamide at Kaiser Permanente →
- Tezepelumab at Kaiser Permanente →
- Tirzepatide at Kaiser Permanente →
- Tofacitinib at Kaiser Permanente →
- Trastuzumab at Kaiser Permanente →
- Upadacitinib at Kaiser Permanente →
- Ustekinumab at Kaiser Permanente →
Generate a Kaiser Permanente PA packet
Open ApprovalHelp — generate a prior-auth packet tailored to Kaiser Permanente's criteria, with prescriber attestation and step-therapy documentation pre-filled.
Get started →Contact: hello@approvalhelp.com